Home » Topics » Regulatory » EMA

EMA
RSS

EMA recommends approval of Abraxane for NSCLC

Jan. 26, 2015

EMA committee recommends approval of Saxenda for weight management

Jan. 26, 2015

Jakavi recommended for approval in Europe for polycythemia vera

Jan. 26, 2015

CHMP issues positive opinion for Prevenar 13 for prevention of pneumococcal pneumonia

Jan. 23, 2015

APR-246 receives European orphan drug designation

Jan. 23, 2015

EMA accepts AstraZeneca's lesinurad MAA for gout

Jan. 22, 2015

UCB confirms regulatory filings for antiepileptic drug brivaracetam

Jan. 22, 2015

EMA grants positive opinion for orphan drug status for enadenotucirev

Jan. 14, 2015

EMA accepts alirocumab MAA for review

Jan. 12, 2015

Celgene receives positive CHMP opinion to extend Revlimid indication

Dec. 24, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...